A Cancer-Specific Monoclonal Antibody against HER2 Exerts Antitumor Activities in Human Breast Cancer Xenograft ModelsMika K. Kaneko, Yukinari Kato|International Journal of Molecular Sciences|2024Cited by 36
Anti‑EpCAM monoclonal antibody exerts antitumor activity against oral squamous cell carcinomasMika K. Kaneko, Yukinari Kato|Oncology Reports|2020Cited by 31
Phosphorylation of <scp>hTERT</scp> at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organsYoko Matsuda, Kenkichi Masutomi, Juanjuan Ye et al.|The Journal of Pathology|2022Cited by 13
Establishment of a Novel Cancer-Specific Anti-HER2 Monoclonal Antibody H2Mab-250/H2CasMab-2 for Breast CancersMika K. Kaneko, Yukinari Kato|Preprints.org|2023Cited by 4
Establishment of a Novel Cancer-Specific Anti-HER2 Monoclonal Antibody H2Mab-250/H2CasMab-2 for Breast CancersMika K. Kaneko, Yukinari Kato|Preprints.org|2023Cited by 3